Prudential Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Prudential Financial's AZN Position: Q4 2024 in Review
Prudential Financial sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 23,831 shares — an estimated $3.71M sold.
Prudential Financial first reported a position in AZN in Q4 2019 and held it in 19 quarters. The position peaked at $3.76M in Q2 2024. 1,220 funds tracked by Wall St. Rank hold AZN as of Q4 2024.
- Prudential Financial reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
- Prudential Financial sold 23,831 AstraZeneca shares in Q4 2024, an estimated $3.71M.
- Prudential Financial first reported a position in AstraZeneca in Q4 2019 and held it in 19 quarters.
- Prudential Financial's AstraZeneca position peaked at $3.76M in Q2 2024.
- 1,220 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.
Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.